We will get a final verdict in 2016 IMO. If there's no data available to share, there isn't much the CEO of a dev stage bio can do to impact share price. What about partnerships you might ask. Well, potential partners may also be waiting for further data before they commit to anything. Hang in there, perhaps be even prepared for further decline. The way I see/spin it is this decline has been due to its financials (burn rate and potential further dilution) but I'm betting on combo prelim data. I will take this opportunity to let the PPS decline further and maybe add some more shares in the $1 range. If the combo data comes out to be good, it will be well worth it IMO. GLTY.
News 
Market Data 
Discover 
